21
https://pubmed.ncbi.nlm.nih.gov/38113975
Twelve novel patient-derived primary cancer cell models from cholangiocarcinoma patients with unique genomic and transcriptomic characteristics and varying drug sensitivities have been established, serving as reliable in vitro models for understanding tumorigenesis and treatment.